The HIV-1 Nucleocapsid Zinc Finger Protein as a Target of Antiretroviral Therapy

E-ISSN： 1873-4294|4|15|1605-1622

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.4, Iss.15, 2004-11, pp. : 1605-1622

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The HIV-1 Nef protein as a target for antiretroviral therapy

By Coleman S.H. Day J.R. Guatelli J.C.

Expert Opinion on Therapeutic Targets, Vol. 5, Iss. 1, 2001-02 ,pp. : 1-22

Informa Healthcare

Access to resources Recommend Favorite

HIV-1 Integration as a Target for Antiretroviral Therapy: A Review

Current Drug Targets - Infectious Disorders, Vol. 1, Iss. 2, 2001-08 ,pp. : 133-149

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the Viral Nucleocapsid Protein in Anti-HIV-1 Therapy

Mini Reviews in Medicinal Chemistry, Vol. 8, Iss. 1, 2008-01 ,pp. : 24-35

Bentham Science Publishers

Access to resources Recommend Favorite

Tipranavir enhances antiretroviral therapy for HIV-1 infections

Inpharma, Vol. 1, Iss. 1550, 2006-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Pharmacokinetics of Antiretroviral Therapy in HIV-1-Infected Children

By Fraaij Pieter L.A. van Kampen Jeroen J.A. Burger David M. Ronald de Groot

Clinical Pharmacokinetics, Vol. 44, Iss. 9, 2005-01 ,pp. : 935-956

Adis International

Access to resources Recommend Favorite